EV
EVIO, Inc.
EVIO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $1.92M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
66 /100
Fair P/S 1.21x
EV/EBITDA 13.57x
PEG N/A
Growth
0 /100
Declining Rev. growth 25.14%
FCF growth N/A
Book val. growth N/A
Profitability
18 /100
Weak FCF margin 45.22%
Op. margin 87.04%
Gross margin 33.02%
Quality
87 /100
Excellent ROA 3.65%
Asset turnover 1.21x
ROIC 28.69%
Debt
1 /100
High Int. coverage 0.33x
Net debt/EBITDA 10.88x
Current ratio 0.04x
Stability
66 /100
Moderate Profitable years 1
EPS volatility 8.86%
Beta -2.39x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EVIO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lori Jean Glauser
Employees
18
Headquarters
Henderson